Galmed Pharmaceuticals
(NASDAQ) GLMD
Galmed Pharmaceuticals Financials at a Glance
Market Cap
$4.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$10.31M
EPS (TTM)
-$2.33
P/E Ratio
-0.24
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$0.56
Volume
37,706
Open
$0.55
Price
$0.56
Volume
37,706
Open
$0.55
Previous Close
$0.56
Daily Range
$0.55 - $0.57
52-Week Range
$0.41 - $2.34
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$0.56
Volume
37,706
Open
$0.55
Previous Close
$0.56
Daily Range
$0.55 - $0.57
52-Week Range
$0.41 - $2.34
Estimated Earnings Date
Jul 30, 2026
GLMD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Galmed Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
Allen J. Baharaff
Website
galmedpharma.comHeadquarters
Ramat Gan, 5250608, IL
GLMD Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-57.04%
Return on Capital
-53.92%
Return on Assets
-55.34%
Earnings Yield
-4.17%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
7.68M
Volume
37.71K
Avg. Volume
3.48M
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$8.51M
EBITDA
-$10.31M
Operating Cash Flow
-$6.32M
Capital Expenditure
$0.00
Free Cash Flow
-$6.32M
Cash & ST Invst.
$18.16M
Total Debt
$0.00
Galmed Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$856.00K
N/A
Employees
5
N/A
Net Income
-$4.82M
-50.1%
EBITDA
-$4.82M
-74.5%
Quarterly Fundamentals
Total Cash
$18.16M
+18.4%
Total Debt
$0.00
N/A
Accounts Receivable
$80.00K
-61.7%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-55.34%
N/A
Return on Invested Capital
-53.92%
N/A
Free Cash Flow
-$1.95M
+1.2%
Operating Cash Flow
-$1.95M
+1.2%